Trevi Therapeutics, Inc. (TRVI) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 34K | 0 | 0 | 0 | 0 | 38K | 0 | 38K | 35K | 35K | 0 | 0 |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | -34K | 0 | 0 | 0 | 0 | -38K | 0 | -38K | -35K | -35K | 0 | 0 |
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | - | 100% | - | 100% | 100% | -8.57% | - | - | - | - | - | - |
| Operating Expenses | 14.91M | 10.22M | 13.92M | 13.72M | 11.47M | 12.21M | 14.09M | 13.25M | 11.87M | 8.9M | 9.04M | 8.38M |
| OpEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Selling, General & Admin | 4.97M | 4.03M | 3.83M | 4.33M | 3.66M | 2.88M | 2.86M | 3.23M | 3.07M | 2.38M | 2.72M | 2.54M |
| SG&A % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Research & Development | 9.94M | 6.19M | 10.09M | 9.39M | 7.81M | 9.33M | 11.22M | 10.02M | 8.8M | 6.52M | 6.32M | 5.84M |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -14.91M | -10.22M | -13.92M | -13.72M | -11.47M | -12.24M | -14.09M | -13.29M | -11.91M | -8.93M | -9.04M | -8.38M |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | -30.01% | 16.52% | 1.21% | -3.26% | 3.66% | -37.05% | -55.74% | -58.54% | -57.42% | -34.19% | -7.61% | -7.19% |
| EBITDA | -14.88M | -10.19M | -13.88M | -13.68M | -11.43M | -12.21M | -14.05M | -13.25M | -11.87M | -8.9M | -9.01M | -8.35M |
| EBITDA Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA Growth % | -30.13% | 16.52% | 1.23% | -3.27% | 3.69% | -37.17% | -55.95% | -58.73% | -57.36% | -33.97% | -7.31% | -6.86% |
| D&A (Non-Cash Add-back) | 34K | 31K | 38K | 38K | 37K | 38K | 36K | 38K | 35K | 35K | 35K | 34K |
| EBIT | -14.91M | -8.33M | -11.82M | -12.32M | -10.35M | -11.4M | -13.27M | -12.36M | -10.91M | -7.8M | -7.71M | -7.02M |
| Net Interest Income | 1.7M | 1.9M | 2.1M | 1.41M | 1.13M | 842K | 825K | 934K | 997K | 1.13M | 1.18M | 1.05M |
| Interest Income | 1.7M | 1.9M | 2.1M | 1.41M | 1.13M | 843K | 826K | 935K | 998K | 1.14M | 1.18M | 1.21M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 1K | 1K | 1K | 1K | 4K | 3K | 151K |
| Other Income/Expense | 1.7M | 1.89M | 2.1M | 1.4M | 1.12M | 844K | 814K | 929K | 996K | 1.13M | 1.33M | 1.21M |
| Pretax Income | -13.21M | -8.33M | -11.82M | -12.32M | -10.35M | -11.4M | -13.27M | -12.36M | -10.91M | -7.8M | -7.71M | -7.17M |
| Pretax Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Income Tax | -20K | -16K | -15K | -21K | -11K | 16K | -31K | -8K | -8K | 18K | -13K | -30K |
| Effective Tax Rate % | 0.15% | 0.19% | 0.13% | 0.17% | 0.11% | -0.14% | 0.23% | 0.06% | 0.07% | -0.23% | 0.17% | 0.42% |
| Net Income | -13.19M | -8.32M | -11.8M | -12.3M | -10.34M | -11.41M | -13.24M | -12.35M | -10.9M | -7.82M | -7.7M | -7.14M |
| Net Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | -27.58% | 27.15% | 10.87% | 0.41% | 5.16% | -45.95% | -72.02% | -72.88% | -70.32% | -42.07% | 6.87% | 11.26% |
| Net Income (Continuing) | -13.19M | -8.32M | -11.8M | -12.3M | -10.34M | -11.41M | -13.24M | -12.35M | -10.9M | -7.82M | -7.7M | -7.14M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.09 | -0.06 | -0.08 | -0.09 | -0.09 | -0.11 | -0.13 | -0.12 | -0.11 | -0.08 | -0.08 | -0.07 |
| EPS Growth % | -3.07% | 48% | 38.46% | 21.33% | 20.09% | -39.95% | -67.74% | -65.75% | -69.49% | -40.11% | 35.42% | 48.29% |
| EPS (Basic) | -0.09 | -0.06 | -0.08 | -0.09 | -0.09 | -0.11 | -0.13 | -0.12 | -0.11 | -0.08 | -0.08 | -0.07 |
| Diluted Shares Outstanding | 145.59M | 145.5M | 145.1M | 130.35M | 117.61M | 106.01M | 101.04M | 101.04M | 99.52M | 99.49M | 99.33M | 98.7M |
| Basic Shares Outstanding | 145.59M | 145.5M | 145.1M | 130.35M | 117.61M | 106.01M | 101.04M | 101.04M | 99.52M | 99.49M | 99.33M | 98.7M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |